Official Publications Astellas Pharma Inc.

Equities

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-06-06 am EDT			5-day change	1st Jan Change
1,586 ^JPY	-0.50%		+4.38%	-5.90%

Jun. 03	US FDA Acknowledges Astellas Pharma's Resubmission of Biologics License Application for Zolbetuximab	MT
May. 31	U.S. Food and Drug Administration Acknowledges Astellas Pharma Inc.? Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date	CI

Slide show Q3	Feb. 04	CO
3rd quarter results	Feb. 04	CO
Slide show half-year results	Oct. 31	CO
Half-year report	Oct. 31	CO
1st-half-year results	Oct. 31	CO
Slide show Q1	23-07-31	CO
1st quarter results	23-07-31	CO
Minutes of the general assembly	23-06-21	CO
Mixed general shareholder meeting	23-05-31	CO
Annual ESG Report	23-04-26	CO
Integrated report	23-04-26	CO
Slide show results	23-04-26	CO
Annual results	23-04-26	CO
Slide show Q3	23-02-05	CO
3rd quarter results	23-02-05	CO
3rd quarter report	23-02-05	CO
Slide show half-year results	22-10-30	CO
1st-half-year results	22-10-30	CO
Integrated report	22-09-29	CO
Financial report	22-08-30	CO
Slide show Q1	22-07-31	CO
1st quarter results	22-07-31	CO
Shareholders meeting voting results	22-06-19	CO
Minutes of the general assembly	22-06-19	CO
Mixed general shareholder meeting	22-05-26	CO